Bottom line
How much do PRHSX and GGHCX overlap?
59% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 47.6% of PRHSX's assets and 48.2% of GGHCX's. They share a meaningful core but differ in the rest of the portfolio.
PRHSX holds far more positions (279 vs 82), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings PRHSX and GGHCX have in common
| Holding | % of PRHSX | % of GGHCX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 14.28% | 10.59% | 10.59% |
| Johnson & Johnson | 6.63% | 6.76% | 6.63% |
| Unitedhealth Group Inc | 5.99% | 6.17% | 5.99% |
| Abbvie Inc | 5.10% | 4.03% | 4.03% |
| Merck & Co. Inc. | 4.01% | 4.59% | 4.01% |
| Gilead Sciences Inc | 2.82% | 3.63% | 2.82% |
| Thermo Fisher Scientific Inc | 2.52% | 1.55% | 1.55% |
| Vertex Pharmaceuticals Inc | 2.28% | 2.01% | 2.01% |
| Guardant Health Inc | 1.23% | 2.04% | 1.23% |
| Cardinal Health Inc | 1.03% | 2.10% | 1.03% |
| Cvs Health Corp | 0.94% | 2.52% | 0.94% |
| Brightspring Health Services | 0.82% | 2.20% | 0.82% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in PRHSX
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
- Intuitive Surgical Inc — 1.87%
- Amgen Inc — 1.82%
- Stryker Corp — 1.78%
- Elevance Health Inc — 1.53%
- Natera Inc — 1.44%
- Danaher Corp — 1.43%
- Royalty Pharma Plc- Cl A — 0.97%
- Tenet Healthcare Corp — 0.94%
- Kymera Therapeutics Inc — 0.89%
- Protagonist Therapeutics Inc — 0.85%
- Moderna Therapeutics Inc — 0.83%
Only in GGHCX
- Invesco Private Prime Fund — 4.67%
- argenx SE — 3.24%
- Welltower Inc. — 2.34%
- Royalty Pharma PLC — 2.13%
- Invesco Private Government Fund — 1.80%
- Axsome Therapeutics, Inc. — 1.58%
- Edwards Lifesciences Corp. — 1.56%
- Invesco Treasury Portfolio — 1.56%
- BridgeBio Pharma, Inc. — 1.43%
- Waters Corp. — 1.41%
- IQVIA Holdings Inc. — 1.32%
- U C B S.a. — 1.24%
- Ligand Pharmaceuticals Inc. — 1.18%
Asset mix
| Asset type | PRHSX | GGHCX |
|---|---|---|
| Stocks | 96.4% | 97.5% |
| Cash & short-term funds | 0.7% | 8.8% |
| Preferred stock | 3.0% | — |
| Bonds | 0.2% | — |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Country mix
| Country | PRHSX | GGHCX |
|---|---|---|
| US | 92.6% | 93.5% |
| NL | 1.0% | 3.4% |
| GB | 1.7% | 3.1% |
| CH | 0.5% | 2.7% |
| BE | — | 1.2% |
| DK | 0.7% | 1.1% |
| IE | 0.8% | 0.6% |
| BM | 0.7% | — |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do PRHSX and GGHCX overlap?
What stocks do PRHSX and GGHCX have in common?
Should I own both PRHSX and GGHCX?
Which holds more stocks, PRHSX or GGHCX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.